
August 9, 2023
Summer funding supports student’s cancer research
UNC-Chapel Hill senior Anna Jin spent her summer in the lab of pediatric oncologist Ian Davis, MD, PhD, researching the use of cancer patients’ own cells to treat Ewing sarcoma.
August 9, 2023
UNC-Chapel Hill senior Anna Jin spent her summer in the lab of pediatric oncologist Ian Davis, MD, PhD, researching the use of cancer patients’ own cells to treat Ewing sarcoma.
January 19, 2023
UNC Lineberger's Ian Davis, MD, PhD, was awarded $1 million by the The V Foundation to support his work to improve CAR-T therapy for pediatric solid tumors.
March 17, 2022
Local football player Troy Ennis and his family go through a rare cancer diagnosis and treatment together, relying on the expertise of UNC Lineberger's Ian Davis, MD.
June 1, 2021
Pengda Liu, PhD, Ian Davis, MD, PhD, and colleagues have discovered a gene, OTUD7A, that impacts the development of Ewing sarcoma, as well as a compound that shows potential to block OTUD7A protein activity.
April 19, 2019
The idea was simple: find the faulty signals that drive cancerous growth in cells, and block them. But what University of North Carolina Lineberger Comprehensive Cancer Center researcher Pengda Liu, PhD, has discovered, when it comes to cancer, even straightforward concepts can become complicated. “When you find a target and inhibit it, you find the …